Serum concentration of homocysteine and the risk of atherosclerosis in patients with obstructive sleep apnea syndrome;Stopień zagrożenia miażdzyca̧ oceniany na podstawie stȩżenia homocysteiny u chorych na obturacyjny bezdech podczas snu

Pneumonologia i Alergologia Polska

Volumn 74, Issue 1, 2006, Pages 117-121

  Kumor, Marta ^a   Rubinsztajn, Renata ^a   Byśkiniewicz, Krzysztof ^a   Bielicki, Piotr ^a   Chazan, Ryszarda ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Atherosclerosis; Homocysteine; Obstructive apnea

Indexed keywords

CHOLESTEROL; FIBRIC ACID DERIVATIVE; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; POLYSOMNOGRAPHY; RISK FACTOR; SLEEP APNEA SYNDROME; SNORING; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ARTERIOSCLEROSIS; BLOOD; COMORBIDITY; EPIDEMIOLOGY; FEMALE; MALE; MIDDLE AGED; REFERENCE VALUE;

ADULT; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CAUSALITY; COMORBIDITY; FEMALE; HOMOCYSTEINE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; REFERENCE VALUES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 33745756236     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pływaczewski R.: Czȩstość i nasilenie zaburzeń oddychania w czasie snu wśród dorosłych mieszkańcow prawobrzeżnej Warszawy. Biblioteka rozpraw habilitacyjnych Instytutu Gruźlicy i Chorób Płuc. Tom 8. Warszawa 2003.
2. Roux F., D'Ambrosio C. i Vahid M.: Sleep - related breathing disorders and cardiovascular disease. Am. J. Med. 2000, 108, 396-402.
3. Nieto F.J., Young T.B., Lind B.K. i wsp.: Association of sleep disoredered breathing, sleep apnea, and hypertension in a large community - based study: Sleep Heart Health Study. JAMA 2000, 283, 1829-36.
4. Peppard P.E., Young T., Palta M. i wsp.: Prospective study of association between sleep - disordered breathing and hypertension. N Engl J Med 2000, 342, 1378 - 84.
5. Hedner J.A., Wilcox I., Laks L. i wsp.: A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am. Rev. Respir. Dis. 1992, 146, 1240-45.
6. Narkiewicz K., van de Borne P.J., Pesek C.A. i wsp.: Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea.: Circulation 1999, 99, 1183-89.
7. Somers V.K., Dyken M.E., Clary M.P. i wsp.: Sympathetic neural mechanisms in obstructive sleep apnea J. Clin. Invest. 1995, 96, 1897-1904.
8. Bonsignore M.R., Marrone O., Insalaco G. i wsp.: The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenetic mechanisms. Eur. Resp. J. 1994, 7, 786-805.
9. Ehlenz K., Peter J.H., Kaffarnik H. i wsp.: Disturbances in volume regulating hormone system- A key to the pathogenesis of hypertension in obstructive sleep apnea syndrome? Pneumologie 1991, 45, 239-45.
10. Leung R.S.T., Bradley D.T: Sleep apnea and cardiovascular disease. State of the art Am. J. Respir. Crit. Care Med. 2001, 164, 2147-65.
11. Ip M.S.M., Lam B., Chan L-Y i wsp.: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am. J. Respir. Crit. Care Med. 2000, 162, 2166-71.
12. Braghiroli A., Sacco C., Erbetta M. i wsp.: Overnight uric acid: creatine ratio for detection of sleep hypoxemia: validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am. J. Rev. Respir. Dis. 1993, 148, 173-78.
13. Chin K., Shimzu K., Nakamura T. i wsp.: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continous positive airway pressure. Circulation 1999, 100, 706-11.
14. Grunstein R.R., Wilcox I., Yang T.S. i wsp.: Snoring and sleep apnea in men: interaction with central obesity and hypertension. Int J Obes. Relat. Metab Disord. 1993, 17, 533-40.
15. Levinson P.D., McGarvey S.T.: Carlisle C.C. i wsp. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 1993, 103, 1336-42.
16. Schäfer H., Pauleit D., Sudhop T. i wsp.: Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002, 122, 829-39.
17. Wilcox I., McNamara S.O., Collins F.L. i wsp.: Syndrome Z: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998, 53, 25-28.
18. Graham I.M., Daly E.L., Refsum H. i wsp.: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project JAMA. 1997, 277, 1775-81.
19. Lim U. i Cassano P.A.: Homocysteine and blood pressure in the Third National and Nutrition Examination Survey, 1988-1994. Am. J. Epidemiol. 2002, 156, 1105-13.
20. Stamler J.S., Osborne J.A., Jarai O. i wsp.: Adverse vascular effects of homocysteine are modulated by endothelium - derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 1993, 91, 308-18.
21. Schulz R., Schmidt D., Blum A. i wsp.: Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnea: response to CPAP therapy. Thorax 2000, 55, 1046-51.
22. Lavie L., Perelman A. i Lavie P.: Plasma homocysteine levels in obstructive sleep apnea Chest 2001, 120, 900-08.
23. Svatikova A., Wolk R., Magera J. i wsp.: Plasma homocysteine in obstructive sleep apnoea. Eur. Heart J. 2004, 25, 1325-29.
24. Robinson G.V., Pepperell J.C.T., Segal H.C. i wsp.: Circulating cardiovascular risk factors in obstructive sleep apnea: data from randomised controlled trials. Thorax 2004, 59, 777-82.
25. Sundström J., Sullivan L., D'Agostino R.B. i wsp.: Plasma homocysteine, hypertension incidence, and blood pressure tracking: The Framingham Heart Study. Hypertension 2003, 42, 1100-105.
26. Jordan W., Berger C., Cohrs S. i wsp.: CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J. Neural. Transm. 2004, 111, 683-89.
27. Kokturk O., Ciftci T.U., Han E.R. i wsp.: Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome. Eur Respir J, 2004, 24, supl. 48, 566.
28. Wald D., Law M. i Morris J.K.: Homocysteine and cardiovascular disease:evidence on casuality from a meta - analysis BMJ 2002, 325, 1202-206.
29. Can M. Acikgoz S., Mungan G. i wsp.: Serum cardiovascular risk factors in obstructive sleep apnea. Chest, 2006, 129, 233-37.